Department of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.
Department of Bioengineering and Therapeutic Sciences, University of California , San Francisco, California 94158, United States.
J Am Chem Soc. 2017 Aug 30;139(34):11650-11653. doi: 10.1021/jacs.7b04030. Epub 2017 Aug 17.
Targeting of cryptic binding sites represents an attractive but underexplored approach to modulating protein function with small molecules. Using the dimeric protease (Pr) from Kaposi's sarcoma-associated herpesvirus (KSHV) as a model system, we sought to dissect a putative allosteric network linking a cryptic site at the dimerization interface to enzyme function. Five cryogenic X-ray structures were solved of the monomeric protease with allosteric inhibitors bound to the dimer interface site. Distinct coordinated movements captured by the allosteric inhibitors were also revealed as alternative states in room-temperature X-ray data and comparative analyses of other dimeric herpesvirus proteases. A two-step mechanism was elucidated through detailed kinetic analyses and suggests an enzyme isomerization model of inhibition. Finally, a representative allosteric inhibitor from this class was shown to be efficacious in a cellular model of viral infectivity. These studies reveal a coordinated dynamic network of atomic communication linking cryptic binding site occupancy and allosteric inactivation of KHSV Pr that can be exploited to target other members of this clinically relevant family of enzymes.
靶向隐匿结合位点是一种有吸引力但尚未充分探索的方法,可以用小分子来调节蛋白质功能。我们以卡波济肉瘤相关疱疹病毒(KSHV)的二聚体蛋白酶(Pr)为模型系统,试图剖析连接二聚体界面隐匿位点与酶功能的假定别构网络。我们解决了五个与别构抑制剂结合的单体蛋白酶的低温 X 射线结构。别构抑制剂所捕捉到的独特协调运动也在室温 X 射线数据和其他二聚体疱疹病毒蛋白酶的比较分析中揭示为替代状态。通过详细的动力学分析阐明了两步机制,并提出了抑制的酶变构模型。最后,该类别的代表性别构抑制剂在病毒感染的细胞模型中显示出疗效。这些研究揭示了一个协调的原子通讯动态网络,将隐匿结合位点占据和 KHSV Pr 的别构失活联系起来,可以利用这个网络来靶向这个具有临床相关性的酶家族的其他成员。